Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Prodia Widyahusada TbkPRWDF 75 Days Sales Outstanding is 26.97 as of Jun. 2026, which is 13% below its 10-year median of 31.15. GuruFocus rates PRWDF with a GF Score™ of 75/100. The stock has 1 warning sign investors should review. Among 201 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 90.55% on this metric.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's Days Sales Outstanding or its related term are showing as below:
PRWDF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.38 Med: 31.15 Max: 33.92
Current: 27.3
During the past 13 years, PT Prodia Widyahusada Tbk's highest Days Sales Outstanding was 33.92. The lowest was 22.38. And the median was 31.15.
PRWDF's Days Sales Outstanding is ranked better than 90.55% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.73
vs PRWDF: 27.30
PT Prodia Widyahusada Tbk's Days Sales Outstanding
increased
from Jun. 2025 (25.87) to Jun. 2026 (26.97).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk Days Sales Outstanding Chart
PRWDF vs TMO, DHR, IDXX: Days Sales Outstanding Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk Days Sales Outstanding vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's Days Sales Outstanding falls into.
PT Prodia Widyahusada Tbk Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (PRWDF) has a Days Sales Outstanding of 26.97 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is 13% below median its historical median of 31.15. Over the past decade, PT Prodia Widyahusada Tbk's Days Sales Outstanding has ranged from 22.38 to 33.92. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #19 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 9.5%.
Is PT Prodia Widyahusada Tbk's Days Sales Outstanding too high?
PT Prodia Widyahusada Tbk's current Days Sales Outstanding of 26.97 is 13% below median its 10-year median of 31.15. Over the past 10 years, this metric has ranged from a low of 22.38 to a high of 33.92. The Medical Diagnostics & Research industry median Days Sales Outstanding is 67.73. PT Prodia Widyahusada Tbk's value of 26.97 is 60.2% below this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #19 out of 201 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Days Sales Outstanding compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #19 out of 201 companies for Days Sales Outstanding. This places PT Prodia Widyahusada Tbk in the top 10% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 67.73. PT Prodia Widyahusada Tbk's value of 26.97 is 60.2% below this benchmark. Historically, PT Prodia Widyahusada Tbk's own Days Sales Outstanding has ranged from 22.38 to 33.92 over the past decade. While the company's 10-year median is 31.15 vs. the industry median of 67.73, PT Prodia Widyahusada Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Diagnostics & Research company?
The median Days Sales Outstanding among Medical Diagnostics & Research companies is 67.73, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current Days Sales Outstanding of 26.97 is 60.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median Days Sales Outstanding is 67.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current Days Sales Outstanding is 26.97, which is 13% below median its own 10-year median of 31.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current Days Sales Outstanding of 26.97. The current Days Sales Outstanding is 26.97, which is 13% below median its 10-year median of 31.15 and 60.2% below the Medical Diagnostics & Research industry median of 67.73. PT Prodia Widyahusada Tbk's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current Days Sales Outstanding is 26.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your 
